Literature DB >> 19133942

Heterogeneous disease modeling for Hardy-Weinberg disequilibrium in case-control studies: application to renal stones and calcium-sensing receptor polymorphisms.

D C Hamilton1, V K Grover, C A Smith, D E C Cole.   

Abstract

Renal stone formation due to hypercalciuria is a relatively common disorder with clear evidence for genetic predisposition, but cryptic phenotypic heterogeneity has hampered identification of candidate genes. The R990G single-nucleotide polymorphism (SNP) of the calcium sensing receptor (CASR) gene has been associated with hypercalciuria in stone formers and shows the appropriate functional phenotype in cell culture. In our preliminary association analysis of a case-control cohort, however, we observed significant Hardy-Weinberg disequilibrium (HWD) for the cases (n= 223), but not controls (n= 676) at the R990G locus, pointing us toward the general disease model incorporating HWD. Because there is an adjacent CASR SNP, A986S, which is in negative linkage disequilibrium with R990G, we extended the general disease model to enable testing of a two-site hypothesis. In our data set, there is no lack of fit (P= .345) for the single-locus model for the R990G genotype, and likelihood ratio testing favors a recessive effect with an eight-fold increase in risk (P < .001) for GG homozygotes, relative to wild-type, based on a population prevalence of 2%. Addition of the A986S genotype provides no additional information either by itself or when included in our two-site model.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19133942     DOI: 10.1111/j.1469-1809.2008.00492.x

Source DB:  PubMed          Journal:  Ann Hum Genet        ISSN: 0003-4800            Impact factor:   1.670


  8 in total

Review 1.  Calcium-sensing receptor 20 years later.

Authors:  Tariq I Alfadda; Ahmad M A Saleh; Pascal Houillier; John P Geibel
Journal:  Am J Physiol Cell Physiol       Date:  2014-05-28       Impact factor: 4.249

Review 2.  Nephrolithiasis secondary to inherited defects in the thick ascending loop of henle and connecting tubules.

Authors:  Nicolas Faller; Nasser A Dhayat; Daniel G Fuster
Journal:  Urolithiasis       Date:  2018-11-20       Impact factor: 3.436

3.  Genetic Polymorphisms and Kidney Stones Around the Globe: A Systematic Review and Meta-Analysis.

Authors:  Abdolreza Mohammadi; Alireza Namazi Shabestari; Leila Zareian Baghdadabad; Fatemeh Khatami; Leonardo Oliveira Reis; Mahin Ahmadi Pishkuhi; Seyed Mohammad Kazem Aghamir
Journal:  Front Genet       Date:  2022-06-30       Impact factor: 4.772

Review 4.  Calcium-sensing receptor: evidence and hypothesis for its role in nephrolithiasis.

Authors:  Giuseppe Vezzoli; Lorenza Macrina; Giulia Magni; Teresa Arcidiacono
Journal:  Urolithiasis       Date:  2018-11-16       Impact factor: 3.436

Review 5.  Calcium-sensing receptor and calcium kidney stones.

Authors:  Giuseppe Vezzoli; Annalisa Terranegra; Francesco Rainone; Teresa Arcidiacono; Mario Cozzolino; Andrea Aloia; Elena Dogliotti; Daniele Cusi; Laura Soldati
Journal:  J Transl Med       Date:  2011-11-22       Impact factor: 5.531

6.  Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India.

Authors:  Manalee Guha; Biswabandhu Bankura; Sudakshina Ghosh; Arup Kumar Pattanayak; Saurabh Ghosh; Dilip Kumar Pal; Anurag Puri; Anup Kumar Kundu; Madhusudan Das
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

Review 7.  The G allele of CaSR R990G polymorphism increases susceptibility to urolithiasis and hypercalciuria: evidences from a comprehensive meta-analysis.

Authors:  Kang Liu; Xiaolan Wang; Jiaxin Ye; Chao Qin; Pengfei Shao; Wei Zhang; Jie Li; Changjun Yin
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

8.  Vitamin D receptor gene polymorphisms and susceptibility to urolithiasis: a meta-regression and meta-analysis.

Authors:  Danyal Imani; Bahman Razi; Arezou Khosrojerdi; Kaivan Lorian; Morteza Motallebnezhad; Ramazan Rezaei; Saeed Aslani
Journal:  BMC Nephrol       Date:  2020-07-10       Impact factor: 2.388

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.